BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: von Haehling S, Arzt M, Doehner W, Edelmann F, Evertz R, Ebner N, Herrmann-Lingen C, Garfias Macedo T, Koziolek M, Noutsias M, Schulze PC, Wachter R, Hasenfuß G, Laufs U. Improving exercise capacity and quality of life using non-invasive heart failure treatments: evidence from clinical trials. Eur J Heart Fail 2021;23:92-113. [PMID: 32392403 DOI: 10.1002/ejhf.1838] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Pieske B, Wachter R, Shah SJ, Baldridge A, Szeczoedy P, Ibram G, Shi V, Zhao Z, Cowie MR; PARALLAX Investigators and Committee members. Effect of Sacubitril/Valsartan vs Standard Medical Therapies on Plasma NT-proBNP Concentration and Submaximal Exercise Capacity in Patients With Heart Failure and Preserved Ejection Fraction: The PARALLAX Randomized Clinical Trial. JAMA 2021;326:1919-29. [PMID: 34783839 DOI: 10.1001/jama.2021.18463] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
2 Kałużna-Oleksy M, Sawczak F, Kukfisz A, Krysztofiak H, Szczechla M, Wleklik M, Przytarska K, Dudek M, Nowak A, Straburzyńska-Migaj E, Uchmanowicz B. The Impact of Clinical, Biochemical, and Echocardiographic Parameters on the Quality of Life in Patients with Heart Failure with Reduced Ejection Fraction. Int J Environ Res Public Health 2021;18:12448. [PMID: 34886173 DOI: 10.3390/ijerph182312448] [Reference Citation Analysis]
3 Cohen-Solal A, Beauvais F. New treatments for heart failure and exercise capacity. Eur J Heart Fail 2021;23:2083-4. [PMID: 34725906 DOI: 10.1002/ejhf.2374] [Reference Citation Analysis]
4 Halle M, Schöbel C, Winzer EB, Bernhardt P, Mueller S, Sieder C, Lecker LSM. A randomized clinical trial on the short-term effects of 12-week sacubitril/valsartan vs. enalapril on peak oxygen consumption in patients with heart failure with reduced ejection fraction: results from the ACTIVITY-HF study. Eur J Heart Fail 2021. [PMID: 34591356 DOI: 10.1002/ejhf.2355] [Reference Citation Analysis]
5 Ma Y, Shi Y, Ma W, Yang D, Hu Z, Wang M, Cao X, Zhang C, Luo X, He S, Zhang M, Duan Y, Cai H. A prospective study on sex differences in functional capacity, quality of life and prognosis in patients with heart failure. Medicine (Baltimore) 2022;101:e29795. [PMID: 35777016 DOI: 10.1097/MD.0000000000029795] [Reference Citation Analysis]
6 Habibzadeh H, Shariati A, Mohammadi F, Babayi S. The effect of educational intervention based on Pender's health promotion model on quality of life and health promotion in patients with heart failure: an experimental study. BMC Cardiovasc Disord 2021;21:478. [PMID: 34610821 DOI: 10.1186/s12872-021-02294-x] [Reference Citation Analysis]
7 Wang YL, Bai L, Shi XR, Zhu H, Du LJ, Liu Y, Ma XX, Lin WZ, Liu T, Sun JY, Liu Y, Guo XG, Zhou LJ, Chen BY, Shao S, Meng XQ, Li YL, Li RG, Duan SZ. Osteoblast MR deficiency protects against adverse ventricular remodeling after myocardial infarction. J Mol Cell Cardiol 2022;167:40-51. [PMID: 35314145 DOI: 10.1016/j.yjmcc.2022.03.003] [Reference Citation Analysis]
8 von Haehling S, Garfias Macedo T, Valentova M, Anker MS, Ebner N, Bekfani T, Haarmann H, Schefold JC, Lainscak M, Cleland JGF, Doehner W, Hasenfuss G, Anker SD. Muscle wasting as an independent predictor of survival in patients with chronic heart failure. J Cachexia Sarcopenia Muscle. 2020;11:1242-1249. [PMID: 32767518 DOI: 10.1002/jcsm.12603] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
9 Klompstra L, Jaarsma T, Strömberg A, Evangelista LS, van der Wal MHL; HF-Wii Study Team. Exercise Motivation and Self-Efficacy Vary Among Patients with Heart Failure - An Explorative Analysis Using Data from the HF-Wii Study. Patient Prefer Adherence 2021;15:2353-62. [PMID: 34703217 DOI: 10.2147/PPA.S314414] [Reference Citation Analysis]
10 Oppedisano F, Mollace R, Tavernese A, Gliozzi M, Musolino V, Macrì R, Carresi C, Maiuolo J, Serra M, Cardamone A, Volterrani M, Mollace V. PUFA Supplementation and Heart Failure: Effects on Fibrosis and Cardiac Remodeling. Nutrients 2021;13:2965. [PMID: 34578843 DOI: 10.3390/nu13092965] [Reference Citation Analysis]
11 Tomasoni D, Adamo M, Metra M. February 2022 at a glance: focus on pathophysiology and acute heart failure. Eur J Heart Fail 2022;24:243-4. [PMID: 35199407 DOI: 10.1002/ejhf.2224] [Reference Citation Analysis]
12 Pagnesi M, Adamo M, Metra M. April 2021 at a glance: focus on systolic function, quality of life and treatment in heart failure. Eur J Heart Fail 2021;23:505-6. [PMID: 34145695 DOI: 10.1002/ejhf.1880] [Reference Citation Analysis]
13 Khan MS, Usman MS, von Haehling S, Doehner W, Stewart Coats AJ. Ferric carboxymaltose for the treatment of iron-deficient heart failure patients: a systematic review and meta-analysis. ESC Heart Fail 2020;7:3392-400. [PMID: 33586856 DOI: 10.1002/ehf2.13146] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Jankowska EA, Kirwan BA, Kosiborod M, Butler J, Anker SD, McDonagh T, Dorobantu M, Drozdz J, Filippatos G, Keren A, Khintibidze I, Kragten H, Martinez FA, Metra M, Milicic D, Nicolau JC, Ohlsson M, Parkhomenko A, Pascual-Figal DA, Ruschitzka F, Sim D, Skouri H, van der Meer P, Lewis BS, Comin-Colet J, von Haehling S, Cohen-Solal A, Danchin N, Doehner W, Dargie HJ, Motro M, Friede T, Fabien V, Dorigotti F, Pocock S, Ponikowski P. The effect of intravenous ferric carboxymaltose on health-related quality of life in iron-deficient patients with acute heart failure: the results of the AFFIRM-AHF study. Eur Heart J 2021:ehab234. [PMID: 34080008 DOI: 10.1093/eurheartj/ehab234] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Tomasoni D, Adamo M, Metra M. May 2022 at a glance. Focus on treatment: from epidemiologic data to randomized trials and new devices. Eur J Heart Fail 2022;24:735-7. [PMID: 35592905 DOI: 10.1002/ejhf.2230] [Reference Citation Analysis]
16 Piepoli MF, Hussain RI, Comin-Colet J, Dosantos R, Ferber P, Jaarsma T, Edelmann F. OUTSTEP-HF: randomised controlled trial comparing short-term effects of sacubitril/valsartan versus enalapril on daily physical activity in patients with chronic heart failure with reduced ejection fraction. Eur J Heart Fail 2021;23:127-35. [PMID: 33314487 DOI: 10.1002/ejhf.2076] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
17 Wiśnicka A, Lomper K, Uchmanowicz I. Self-care and quality of life among men with chronic heart failure. Front Public Health 2022;10:942305. [DOI: 10.3389/fpubh.2022.942305] [Reference Citation Analysis]
18 Ravera A, Santema BT, Sama IE, Meyer S, Lombardi CM, Carubelli V, Ferreira JP, Lang CC, Dickstein K, Anker SD, Samani NJ, Zannad F, van Veldhuisen DJ, Teerlink JR, Metra M, Voors AA. Quality of life in men and women with heart failure: association with outcome, and comparison between the Kansas City Cardiomyopathy Questionnaire and the EuroQol 5 dimensions questionnaire. Eur J Heart Fail 2021;23:567-77. [PMID: 33728762 DOI: 10.1002/ejhf.2154] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Cousino MK, Lim HM, Smith C, Yu S, Lowery R, Viers S, McCormick AD, Peng DM, Uzark K, Schumacher KR. Primary Disease, Sex, and Racial Differences in Health-Related Quality of Life in Adolescents and Young Adults with Heart Failure. Pediatr Cardiol 2022. [PMID: 35378609 DOI: 10.1007/s00246-022-02884-2] [Reference Citation Analysis]
20 Tomasoni D, Adamo M, Metra M. January 2021 at a glance: focus on sex differences, acute heart failure and exercise capacity. Eur J Heart Fail 2021;23:1-2. [PMID: 33725389 DOI: 10.1002/ejhf.1874] [Reference Citation Analysis]
21 Segev A, Itelman E, Avaky C, Negru L, Shenhav-Saltzman G, Grupper A, Wasserstrum Y, Segal G. Low ALT Levels Associated with Poor Outcomes in 8700 Hospitalized Heart Failure Patients. J Clin Med 2020;9:E3185. [PMID: 33008125 DOI: 10.3390/jcm9103185] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]